Metoprololtartraat Retard Cf (Metoprolol Tartrate)

Metoprolol Tartrate works by competitively blocking β1‑adrenergic receptors in the heart. This reduces heart rate, myocardial contractility, and cardiac output, leading to lower blood pressure and decreased oxygen demand by the heart muscle. The drug also suppresses renin release from the kidneys, contributing to its antihypertensive effect.

The appropriate dose of Metoprololtartraat Retard Cf is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors such as renal function. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety data for metoprolol tartrate in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss treatment options with their physician.

To place an order, visit the product page on gnhindia.com, enter the required quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metoprolol tartrate is a β1‑selective blocker, offering cardiac‑specific effects with fewer respiratory side effects compared with non‑selective agents like propranolol. Compared with atenolol, another β1‑selective blocker, metoprolol has a shorter half‑life and may require more frequent dosing, but both share similar efficacy for hypertension and angina.

Store the tablets below 25 °C in their original container, protected from moisture and direct sunlight. Do not expose the product to excessive heat or humidity. Keep out of reach of children and dispose of any unused medication according to local regulations.

Metoprololtartraat Retard Cf is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions of their prescriber. The tablets should be swallowed whole and not crushed or chewed to maintain the intended release profile.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with reactive airway disease, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, severe dizziness, difficulty breathing, or signs of an allergic response.

Metoprololtartraat Retard Cf is contraindicated in patients with known hypersensitivity to metoprolol or any excipients, those with severe bradycardia, second‑ or third‑degree AV block without a pacemaker, cardiogenic shock, and uncontrolled heart failure. Caution is also advised for individuals with severe asthma or chronic obstructive pulmonary disease.